Characterization of 17-dihydroexemestane glucuronidation: potential role of the UGT2B17 deletion in exemestane pharmacogenetics [0.03%]
17-二氢 exemestane 的葡萄糖醛酸化特性:UGT2B17 缺失在 exemestane 药物基因组学中的潜在作用
Dongxiao Sun,Gang Chen,Ryan W Dellinger et al.
Dongxiao Sun et al.
Objective: Exemestane is a third-generation aromatase inhibitor used in the treatment of breast cancer in postmenopausal women. Reduction to form 17-dihydroexemestane and subsequent glucuronidation to exemestane-17-O-gluc...
Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase [0.03%]
细胞色素P450还原酶基因变异通过底物特异性调节CYP3A4活性
Vishal Agrawal,Ji Ha Choi,Kathleen M Giacomini et al.
Vishal Agrawal et al.
Objectives: CYP3A4 receives electrons from P450 oxidoreductase (POR) to metabolize about 50% of clinically used drugs. There is substantial inter-individual variation in CYP3A4 catalytic activity that is not explained by ...
Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil [0.03%]
一型及二型次黄嘌呤单磷酸脱氢酶基因多态性与吗替麦考酚酯治疗效果的相关性研究
Olivier Gensburger,Ron H N Van Schaik,Nicolas Picard et al.
Olivier Gensburger et al.
Background: Type I and II inosine monophosphate dehydrogenases (IMPDH) are the targets of mycophenolic acid (MPA), a widely used immunosuppressant. The aims of this study were: to check the presence of controversial polym...
Development of new HLA-B*3505 genotyping method using Invader assay [0.03%]
一种新的Invader技术HLA-B*3505基因分型方法的建立
Naoya Hosono,Soranun Chantarangsu,Kazuma Kiyotani et al.
Naoya Hosono et al.
Several pharmacogenetic studies have revealed strong associations between specific human leukocyte antigen (HLA) alleles and the susceptibility to drug hypersensitivity. Recently, we reported HLA-B*3505 as a strong genetic biomarker for the...
Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients [0.03%]
中国患者对罗苏伐他汀的脂质反应的药物基因组分析
Miao Hu,Sandra S H Lui,Valiant W L Mak et al.
Miao Hu et al.
Lipid changes with statin treatments vary greatly between individuals for reasons which are largely unknown. This study was performed to examine the genetic determinants of lipid responses to rosuvastatin in Chinese patients. A total of 125...
Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention [0.03%]
髓样分化表达基因2和 Toll _like 受体4基因多态性与经皮冠状动脉介入治疗后临床及血管内超声评估的再狭窄无关
Marcel A M Beijk,S Matthijs Boekholdt,Saskia Z H Rittersma et al.
Marcel A M Beijk et al.
Objective: Restenosis after percutaneous coronary intervention (PCI) remains an issue even in the drug-eluting stent era. Genetic polymorphisms may provide insight in the pathogenesis of restenosis and may help in the str...
DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia [0.03%]
多巴胺D2受体基因启动区的遗传变异可预测首次发病精神分裂症患者抗精神病药物所致的体重增加
Todd Lencz,Delbert G Robinson,Barbara Napolitano et al.
Todd Lencz et al.
Many antipsychotic medications carry a substantial liability for weight gain, and one mechanism common to all antipsychotics is binding to the dopamine D2 receptor. We therefore examined the relationship between -141C Ins/Del (rs1799732), a...
Randomized Controlled Trial
Pharmacogenetics and genomics. 2010 Sep;20(9):569-72. DOI:10.1097/FPC.0b013e32833ca24b 2010
The metabotropic glutamate receptor subtype 5 mediates sensitivity to the sedative properties of ethanol [0.03%]
代谢型谷氨酸受体5亚型介导乙醇的镇静作用
Chris Downing,Michael J Marks,Colin Larson et al.
Chris Downing et al.
Objective: Inbred long-sleep and short-sleep mice (ILS and ISS) were selectively bred for differential sensitivity to the sedative effects of ethanol. Lines of mice derived from these progenitors have been used to identif...
PharmGKB summary: very important pharmacogene information for CYP2B6 [0.03%]
PharmGKB总结:CYP2B6非常重要药物基因信息
Caroline F Thorn,Jatinder K Lamba,Vishal Lamba et al.
Caroline F Thorn et al.
Genome-wide association studies in pharmacogenomics: successes and lessons [0.03%]
基因组范围关联研究在药物基因组学中的应用:成果与启示
Alison A Motsinger-Reif,Eric Jorgenson,Mary V Relling et al.
Alison A Motsinger-Reif et al.
Objective: As genotyping technology has progressed, genome-wide association studies (GWAS) have matured into efficient and effective tools for mapping genes underlying human phenotypes. ...